Lv1
100 积分 2026-03-25 加入
Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses
1个月前
已完结
Diagnostic performance of IOTA SR and O-RADS combined with CA125, HE4, and risk of malignancy algorithm to distinguish benign and malignant adnexal masses
1个月前
已完结
Diagnostic performance of a modified O-RADS classification system for adnexal lesions incorporating clinical features
1个月前
已完结
Clinical value of O-RADS combined with serum CA125 and HE4 for the diagnosis of ovarian tumours
1个月前
已完结
Clinical value of O-RADS combined with serum CA125 and HE4 for the diagnosis of ovarian tumours
1个月前
已完结
Predictive value of serum HE4 and CA125 concentrations for lymphatic metastasis of endometrial cancer
1个月前
已完结
The Utility of Preoperative Serum CA125 Combined with HE4 to Predict Lymph Node Metastasis in Endometrial Cancer
1个月前
已完结
Value of preoperative neutrophil–lymphocyte ratio and human epididymis protein 4 in predicting lymph node metastasis in endometrial cancer patients
1个月前
已完结
Novel algorithm including CA-125, HE4 and body mass index in the diagnosis of endometrial cancer
1个月前
已完结
Value of preoperative neutrophil–lymphocyte ratio and human epididymis protein 4 in predicting lymph node metastasis in endometrial cancer patients
1个月前
已完结
皖公网安备34019202002308
